“Legal Highs” – New Players in the Old Drama
Current Drug Abuse Reviews June 1, 2011 DOI: 10.2174/1874473711104020122 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Citations | 61 |
| Key findings | The review categorizes "legal highs" into three groups—psychostimulants, hallucinogens, and synthetic cannabinoids—and discusses their pharmacological properties and negative consequences, indicating that these products pose significant health risks despite their legal status. |
Abstract
Recently, a new class of “designer drugs” has emerged on the drug use market, known as “legal highs” or “herbal highs”. They include a wide range of products, from natural plant-originated substances to synthetic compounds, that can be purchased both online and from high street retailers. “Legal highs” mimic psychoactive effects of illicit drugs of abuse. However, they are claimed to consist of compounds that are legal to sell, possess and use. Based on the spectrum of their actions on the cognitive processes, mood, and behavior “legal highs” can be classified into three basic categories: amphetamine- and ecstasy-like psychostimulants, hallucinogens, and synthetic cannabinoids (“spice”). This review surveys the current state of knowledge regarding the pharmacological properties of “legal highs”. It also addresses the negative consequences of using these products. Keywords: “Legal highs”, “spice”, mephedrone, benzylpiperazine, salvinorin A, lysergamide, synthetic cannabinoids, psychoactive compounds, mimic psychoactive effects, illicit drugs
Citations in the library
Cited by 14
- Beyond THC: The New Generation of Cannabinoid Designer Drugs Frontiers in Behavioral Neuroscience 2011
- Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology March 1, 2012
- “Not for Human Consumption”: A Review of Emerging Designer Drugs Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy April 8, 2014
- Methoxetamine (MXE) – A Phenomenological Study of Experiences Induced by a “Legal High” from the Internet Journal of Psychoactive Drugs July 1, 2013
- 5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects. Toxicology Letters March 27, 2013
and 9 more in the library
Cites 30
- Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences September 3, 2002
- Opioid receptors and legal highs:Salvia divinorumand Kratom Clinical Toxicology 2008
- Instability of the ecstasy market and a new kid on the block: mephedrone Journal of Psychopharmacology September 8, 2010
- Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations. Journal of Pharmacology and Experimental Therapeutics March 1, 2004
- Hallucinogens and dissociative agents naturally growing in the United States. Pharmacology & Therapeutics May 1, 2004
and 25 more in the library